CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65

gurufocus.com · 2026-09-02

CareDx Inc (CDNA) Analyst Rating Update On October 3, 2023, CareDx (CDNA) received a new analyst rating as Canaccord Genuity, represented by analyst Kyle Mik

TickrTrends take: Canaccord Genuity's initiation of coverage with a $65 price target provides an external valuation benchmark for CDNA at a time when TickrTrends' analysis indicates the stock is trading at overvalued levels. For investors focused on valuation metrics in the Healthcare sector, this analyst target represents a reference point to monitor against the company's current trading price and whether CDNA's valuation premium can be justified by fundamental performance. The convergence or divergence between this newly established price target and CDNA's actual trading levels may signal whether market sentiment is shifting relative to the overvaluation assessment.

Read the full story at gurufocus.com →